Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


OLIENA
Language recovery after stroke
App | Video | PDF (278 pp) | Web

  Alzheimer's Disease

  Free Subscription


Articles published in Neuroreport

Retrieve available abstracts of 12 articles:
HTML format
Text format



Single Articles


    September 2018
  1. HESHMATI-FAKHR N, Sotoodehnejadnematalahi F, Yousefi N, Sayyah M, et al
    Triggering microglia through toll-like receptor 2 pathway induced interferon beta expression in cell and animal model of Alzheimer's disease.
    Neuroreport. 2018 Sep 14. doi: 10.1097/WNR.0000000000001132.
    PubMed     Text format     Abstract available


    August 2018
  2. ZHONG Z, Yuan K, Tong X, Hu J, et al
    MiR-16 attenuates beta-amyloid-induced neurotoxicity through targeting beta-site amyloid precursor protein-cleaving enzyme 1 in an Alzheimer's disease cell model.
    Neuroreport. 2018 Aug 23. doi: 10.1097/WNR.0000000000001118.
    PubMed     Text format     Abstract available


    July 2018
  3. MACHADO AE, de Sousa G, Mancini G, Faria MS, et al
    Hypercholesterolemia impairs contextual fear conditioning memory formation in female mice: evidence for cholinergic dysfunction.
    Neuroreport. 2018 Jul 9. doi: 10.1097/WNR.0000000000001091.
    PubMed     Text format     Abstract available


  4. LI H, Zheng L, Jiang A, Mo Y, et al
    Identification of the biological affection of long noncoding RNA BC200 in Alzheimer's disease.
    Neuroreport. 2018 Jul 3. doi: 10.1097/WNR.0000000000001057.
    PubMed     Text format     Abstract available


    June 2018
  5. HODGES SL, Reynolds CD, Smith GD, Jefferson TS, et al
    Molecular interplay between hyperactive mammalian target of rapamycin signaling and Alzheimer's disease neuropathology in the NS-Pten knockout mouse model.
    Neuroreport. 2018 Jun 29. doi: 10.1097/WNR.0000000000001081.
    PubMed     Text format     Abstract available


    February 2018
  6. OH M, Seo M, Oh SY, Kim H, et al
    Clinical significance of visually equivocal amyloid PET findings from the Alzheimer's Disease Neuroimaging Initiative cohort.
    Neuroreport. 2018 Feb 12. doi: 10.1097/WNR.0000000000000986.
    PubMed     Text format     Abstract available


    January 2018
  7. DONG H, Wu S, Hu N, Xing G, et al
    Efficacy of tenuigenin and beta-asarone as augmentations for memantine in the treatment of Alzheimer's disease.
    Neuroreport. 2018 Jan 2. doi: 10.1097/WNR.0000000000000952.
    PubMed     Text format     Abstract available


    December 2017
  8. XUE SW, Guo Y
    Increased resting-state brain entropy in Alzheimer's disease.
    Neuroreport. 2017 Dec 12. doi: 10.1097/WNR.0000000000000942.
    PubMed     Text format     Abstract available


    September 2017
  9. THOMAS RS, Alsaqati M, Bice JS, Hvoslef-Eide M, et al
    Alterations in endocytic protein expression with increasing age in the transgenic APP695 V717I London mouse model of amyloid pathology: implications for Alzheimer's disease.
    Neuroreport. 2017 Sep 6. doi: 10.1097/WNR.0000000000000861.
    PubMed     Text format     Abstract available


    May 2017
  10. GUO Y, Zhao Y, Nan Y, Wang X, et al
    (-)-Epigallocatechin-3-gallate ameliorates memory impairment and rescues the abnormal synaptic protein levels in the frontal cortex and hippocampus in a mouse model of Alzheimer's disease.
    Neuroreport. 2017 May 17. doi: 10.1097/WNR.0000000000000803.
    PubMed     Text format     Abstract available


    January 2017
  11. XU LL, Shen Y, Wang X, Wei LF, et al
    Mitochondrial dynamics changes with age in an APPsw/PS1dE9 mouse model of Alzheimer's disease.
    Neuroreport. 2017 Jan 21. doi: 10.1097/WNR.0000000000000739.
    PubMed     Text format     Abstract available


    November 2016
  12. JANG S, Lee JH, Sohn BK, Kim E, et al
    Suppression of AIMP1 protects cognition in Alzheimer's disease model mice 3xTg-AD.
    Neuroreport. 2016.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Alzheimer's Disease is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: